Lupromax Pelumas Indonesia Tbk. vs Merck Tbk. — how do they compare? Lupromax Pelumas Indonesia Tbk. trades at Rp114 (market cap 72.8B, 1.16M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 23.4× Lupromax Pelumas Indonesia Tbk.'s market cap, and Lupromax Pelumas Indonesia Tbk. is more actively traded (1.16M versus 37.6K). Which is the better fit depends on your goals.
| LMAX | MERK | |
|---|---|---|
Market Cap | 72.8B | 1.7T |
Volume | 1.16M | 37.6K |
Lot | 11.62K | 376 |
Turnover | 135.77M | 144.47M |
Average Price | 116.8 | 3,842.23 |
Value | 135.77M | 144.47M |
Indicative Equilibrium Price | 114 | 3,840 |
Indicative Equilibrium Volume | 427 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lupromax Pelumas Indonesia Tbk formerly PT Karya Pelumas Indonesia (the Company) was established based on Notarial Deed No. 42 dated February 27, 2017 of Meissie Pholuan, S.H., notary in Jakarta. The Company started its commercial operations in 2017.
Read more on LMAX →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →